Acute Asthma Clinical Trial
Official title:
Phase 4 Study of Oral Montelukast Hospitalized Preschool Children
Leukotriene receptor antagonists (LTRAs) are well established in the management of outpatient
asthma. Montelukast is a potent, specific, orally active, cysteinyl leukotriene receptor
antagonist with a rapid onset of action.However, there is very little information as to their
role in acute asthma exacerbations.
The purpose of this study is to determine if adding oral montelukast to the maximal standard
treatment in children hospitalized for acute asthma has any additive benefit.
Background: Montelukast is a potent, specific, orally active, cysteinyl leukotriene receptor
antagonist with a rapid onset of action.
Objective: To evaluate the effect of the addition of a single dose of oral montelukast to
standard therapy in acute asthma. Design: Double-blind, randomised, controlled, parallel
group trial. Setting: Pediatric service of Education and training Hospital Patients: Children
with the ages of 6-60 months who were hospitalized for acute asthma Intervention: Children
received montelukast 4 mg or placebo orally in addition to the standard therapy. Clinical
asthma score was recorded before administering study medication and thereafter, 4 hourly
until discharge. Main outcome measure: The primary outcome was discharge rates.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01429415 -
Magnesium Nebulization Utilization in Management of Pediatric Asthma
|
Phase 2 | |
| Completed |
NCT01196377 -
Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study
|
N/A | |
| Completed |
NCT00733473 -
Nebulized Budesonide for Children Who Are Hospitalized for Acute Wheezing
|
Phase 4 | |
| Completed |
NCT00733317 -
Budesonide for Emergency Treatment of Acute Wheezing in Children
|
Phase 4 | |
| Completed |
NCT01695031 -
Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens
|
N/A | |
| Recruiting |
NCT04016220 -
Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma
|
Phase 1 | |
| Active, not recruiting |
NCT06005337 -
Supporting Parents to Choose Wisely
|
N/A | |
| Completed |
NCT01079000 -
Emergency Department (ED)-Directed Interventions to Improve Asthma Outcomes
|
N/A | |
| Completed |
NCT00922350 -
Heliox and Posture in Patients With Asthma
|
N/A | |
| Completed |
NCT03698630 -
Single Dose Oral Dexamethasone Versus Multi-dose Prednisolone in the Treatment of Acute Exacerbations of Asthma in Children
|
Phase 4 | |
| Terminated |
NCT00819637 -
A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
|
Phase 4 | |
| Completed |
NCT01868113 -
Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial
|
Phase 3 | |
| Completed |
NCT01016444 -
Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms
|
||
| Completed |
NCT00393367 -
Budesonide Inhalation Suspension for Acute Asthma in Children
|
Phase 4 | |
| Completed |
NCT01304901 -
Effect of Addition of Single Dose of Oral Montelukast to Standard Treatment in Acute Asthma in Preschool Children.
|
Phase 4 | |
| Completed |
NCT01403467 -
Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma Exacerbation
|
Phase 4 |